Correlation Between ANI Pharmaceuticals and Phibro Animal

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ANI Pharmaceuticals and Phibro Animal at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ANI Pharmaceuticals and Phibro Animal into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ANI Pharmaceuticals and Phibro Animal Health, you can compare the effects of market volatilities on ANI Pharmaceuticals and Phibro Animal and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ANI Pharmaceuticals with a short position of Phibro Animal. Check out your portfolio center. Please also check ongoing floating volatility patterns of ANI Pharmaceuticals and Phibro Animal.

Diversification Opportunities for ANI Pharmaceuticals and Phibro Animal

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between ANI and Phibro is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding ANI Pharmaceuticals and Phibro Animal Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phibro Animal Health and ANI Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ANI Pharmaceuticals are associated (or correlated) with Phibro Animal. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phibro Animal Health has no effect on the direction of ANI Pharmaceuticals i.e., ANI Pharmaceuticals and Phibro Animal go up and down completely randomly.

Pair Corralation between ANI Pharmaceuticals and Phibro Animal

Given the investment horizon of 90 days ANI Pharmaceuticals is expected to under-perform the Phibro Animal. But the stock apears to be less risky and, when comparing its historical volatility, ANI Pharmaceuticals is 1.52 times less risky than Phibro Animal. The stock trades about -0.03 of its potential returns per unit of risk. The Phibro Animal Health is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  1,265  in Phibro Animal Health on August 27, 2024 and sell it today you would earn a total of  1,109  from holding Phibro Animal Health or generate 87.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ANI Pharmaceuticals  vs.  Phibro Animal Health

 Performance 
       Timeline  
ANI Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ANI Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's forward indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.
Phibro Animal Health 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Phibro Animal Health are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical indicators, Phibro Animal exhibited solid returns over the last few months and may actually be approaching a breakup point.

ANI Pharmaceuticals and Phibro Animal Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ANI Pharmaceuticals and Phibro Animal

The main advantage of trading using opposite ANI Pharmaceuticals and Phibro Animal positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ANI Pharmaceuticals position performs unexpectedly, Phibro Animal can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phibro Animal will offset losses from the drop in Phibro Animal's long position.
The idea behind ANI Pharmaceuticals and Phibro Animal Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets